BLRX
Bioline Rx Ltd ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.67
+0.01 ▲ +0.38%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$2.66
-0.01 ▼ -0.37%
| Index | - | P/E | - | EPS (ttm) | -1.37 | Insider Own | 0.56% | Shs Outstand | 0.00B | Perf Week | 0.75% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | -35.29% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -9.49% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -0.39 | Inst Own | 1.1% | Short Float | 3.91% | Perf Quarter | -19.34% |
| Income | -0.00B | P/S | 0.9 | EPS this Y | 94.33% | Inst Trans | 11.48% | Short Ratio | 10.11 | Perf Half Y | -33.42% |
| Sales | 0.01B | P/B | 0.59 | EPS next 5Y | 57.36% | ROA | -6.73% | Short Interest | 0.17M | Perf YTD | -3.61% |
| Book/sh | 4.49 | P/C | 0.46 | EPS past 3/5Y | 42.57% 46.37% | ROE | -22.22% | 52W High | -65.64% ($7.77) | Perf Year | -12.46% |
| Cash/sh | 5.8 | P/FCF | - | Sales past 3/5Y | - | ROIC | -11.92% | 52W Low | 16.08% ($2.30) | Perf 3Y | -88.64% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 87.3% | Gross Margin | 46.19% | Volatility(W/M) | 5.18% 6.13% | Perf 5Y | -97.8% |
| Dividend TTM | - | EV/Sales | -0.17 | Sales Y/Y TTM | -41.71% | Oper. Margin | -80.95% | ATR (14) | 0.16 | Perf 10Y | -99.58% |
| Dividend Ex-Date | - | Quick Ratio | 1.93 | EPS Q/Q | 92.34% | Profit Margin | -24.27% | RSI (14) | 38.99 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.09 | Sales Q/Q | -91.32% | SMA20 | -3.85% ($2.78) | Beta | 1.32 | Target Price | $17.5 |
| Payout | - | Debt/Eq | 0.58 | Earnings | 11000000 | SMA50 | -7.43% ($2.88) | Rel Volume | 0.44 | Prev Close | $2.66 |
| Employees | 28 | LT Debt/Eq | 0.34 | EPS/Sales Surpr. | 100% -56.87% | SMA200 | -26.59% ($3.64) | Avg Volume(3M) | 0.02M | Price | $2.67 |
| IPO | 2011/7/25 | Option/Short | Yes/Yes | Trades | 79 | Volume | 7,429 | Change | 0.38% |
뉴스 로딩 중...